TITLE

Drug Therapy of Cardiovascular Risk Factors: Guidelines versus Reality in Primary Health Care Service

AUTHOR(S)
Marković, Biserka Bergman; Kranjčević, Ksenija; Reiner, Željko; Blažeković, Sanja Milaković; Špehar, Stanka Stojanović
PUB. DATE
December 2005
SOURCE
Croatian Medical Journal;2005, Vol. 46 Issue 6, p984
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Aim To determine the monthly costs of prescription drugs for the treatment of hypertension, hypercholesterolemia, and diabetes mellitus and their share in the total prescription drugs expenditures allowed by the Croatian Institute for Health Insurance. Methodology Hypertension, hypercholesterolemia, and diabetes mellitus were diagnosed in 4,916 patients in three general practitioner (GP) offices in the Zagreb area in January 2005. The monthly cost of medications prescribed by the GPs for the treatment of these three diseases was obtained by summarizing the prices of all antihypertensive, lipid-lowering, and antidiabetic drugs prescribed in one month. The monthly medication costs for each disease separately and all three diseases together were compared with the total prescription drug expenditures approved by the Croatian Institute for Health Insurance. Results Hypertension was diagnosed in 1,112 (22.6%), hypercholesterolemia in 324 (6.5%), and diabetes mellitus in 359 (7.3%) patients. Monthly cost of all medications prescribed for these three diseases accounted for 81.2% of the total amount approved for medications by the Croatian Institute for Health Insurance. Antihypertensive drugs accounted for 51.1%, antidiabetic drugs for 11.7% for, and lipid-lowering treatment for 18.4%. The medications were prescribed most often to patients older than 65 years (93.6%). Conclusion GPs are strongly obligated by the annual contract with the Croatian Institute for Health Insurance to keep the medication expenses within the approved amount. However, the approved amount is spent mostly on the drug treatment of hypertension, hypercholesterolemia, and diabetes mellitus as the main cardiovascular risk factors.
ACCESSION #
19141860

 

Related Articles

  • Antihypertensive Drug Therapy and Coronary Heart Disease Risk. Schoenberger, James A. // Journal of Family Practice;Jan1993, Vol. 36 Issue 1, p70 

    Coronary heart disease (CHD) is the major cause of death in the United States. Major modifiable risk factors for CHD are hypertension, hypercholesterolemia, and cigarette smoking, with concomitant risk factors, especially left ventricular hypertrophy, that act synergistically to significantly...

  • Managing blood pressure and lipids in diabetes in primary care. Inglis, Andrew // Practice Nursing;Feb2012, Vol. 23 Issue 2, p82 

    The article discusses the administration of blood pressure and lipids for type 2 diabetes in primary care. It also tackles the treatment for patients with type 1 diabetes. The recommendation of the National Institute for Health and Clinical Excellence (NICE) in Great Britain on blood pressure...

  • Performance of Comorbidity, Risk Adjustment, and Functional Status Measures in Expenditure Prediction for Patients With Diabetes. Maciejewski, Matthew L.; Liu, Chuan-Fen; Fihn, Stephan D. // Diabetes Care;Jan2009, Vol. 32 Issue 1, p75 

    OBJECTIVE -- To compare the ability of generic comorbidity and risk adjustment measures, a diabetes-specific measure, and a self-reported functional status measure to explain variation in health care expenditures for individuals with diabetes. RESEARCH DESIGN AND METHODS -- This study included a...

  • Blood Pressure-Lowering Aspects of Lipid-Lowering and Anti-Diabetic Drugs. Nilsson, Peter M.; Cifkova, Renata // Pharmaceuticals;Jan2011, Vol. 4 Issue 1, p1 

    Several studies have shown that blood pressure can be lowered by the use of drugs that are not traditional antihypertensive drugs. This might be of clinical importance when many risk patients are treated by combination drug therapy in order to prevent cardiovascular disease by way of improving...

  • Hypertension Management: An Update. Quang Nguyen; Dominguez, Joann; Loida Nguyen; Gullapalli, Nageshwara // American Health & Drug Benefits;Jan2010, Vol. 3 Issue 1, p47 

    Hypertension is a significant and costly public health problem. It is a major, but modifiable contributor for the development of cardiovascular disease. Randomized controlled trials have shown that controlling hypertension reduces the risk of stroke, coronary artery disease, congestive heart...

  • Systematic Detection of Familial Hypercholesterolaemia in Primary Health Care: A Community Based Prospective Study of Three Methods. Kirke, Andrew B.; Barbour, Rita A.; Burrows, Sally; Bell, Damon A.; Vickery, Alistair W.; Emery, Jon; Watts, Gerald F. // Heart, Lung & Circulation;Mar2015, Vol. 24 Issue 3, p250 

    Background Familial hypercholesterolaemia (FH), a co-dominantly inherited disease of cholesterol that markedly increases risk of premature coronary artery disease (CAD), is significantly under-diagnosed. Primary health care is increasingly seen as a setting in which to increase the detection...

  • Evaluation of thiazide diuretic use as preferred therapy in uncomplicated essential hypertension patients. Greene, Ronald S.; Quinones, Marissa Escobar; Edwards, Krystal L. // Pharmacy Practice (18863655);Jul2007, Vol. 5 Issue 3, p130 

    Thiazide diuretics are effective antihypertensive medications shown to reduce the risk of cardiovascular events and stroke. Despite being the preferred choice for uncomplicated essential hypertension, thiazide diuretics continue to be underutilized. Methods: Uncomplicated essential hypertension...

  • Managing hypertension in type 2 diabetes. Gadsby, Roger // Diabetes & Primary Care;2013, Vol. 15 Issue 5, p257 

    People with diabetes are at a high risk of developing vascular complications, all of which are known to be reduced by optimal blood pressure (BP) management. Type 2 diabetes is itself associated with hypertension, increasing the already high cardiovascular risk in this population. A variety of...

  • Preventing stroke in people with atrial fibrillation: a cross-sectional study. de Lusignan, Simon; Van Vlymen, Jeremy; Hague, Nigel; Thana, Lavanya; Dzregah, Billy; Chan, Tom // Journal of Public Health;Mar2005, Vol. 27 Issue 1, p85 

    Background The annual stroke rate in atrial fibrillation is around 5 per cent with increased risk in those with hypertension, diabetes, left ventricular dysfunction and other cardiovascular risk factors. This study set out to identify the patients with atrial fibrillation and modifiable risk...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics